Clinical trial

Tysabri Observational Program

NCT00493298

StatusCOMPLETED

Study typeOBSERVATIONAL

Start date2007-06-29

PhaseN/A

Study timeline

Study start (actual)2007-06-29Date precision: day

Registry last updated2024-04-08

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Relapsing-Remitting Multiple Sclerosisverified · MONDO: relapsing-remitting multiple sclerosis

Interventions

TysabriDRUG · verified · RxNorm: Tysabri

Sponsors & collaborators

Biogenlead sponsor

Mapped research locations

BerlinGermany10 Mexico CityMexico6 AthensGreece5 MünchenGermany5 PragueCzechia4 Buenos AiresArgentina4 HamburgGermany3 RomaItaly3 EssenGermany3 ThessalonikiGreece3 BratislavaSlovakia3 UlmGermany3

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00493298 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.